{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T16:30:41Z","timestamp":1789230641049,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82430109"],"award-info":[{"award-number":["82430109"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22137004"],"award-info":[{"award-number":["22137004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22541704"],"award-info":[{"award-number":["22541704"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejmech.2026.119005","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T15:00:48Z","timestamp":1779721248000},"page":"119005","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of a potent and selective small-molecule inhibitor of ubiquitin-specific peptidase 15 (USP15) for the treatment of breast cancer"],"prefix":"10.1016","volume":"316","author":[{"given":"Tuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xincheng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingting","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9762-4818","authenticated-orcid":false,"given":"Hang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.119005_bib1","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev.biochem.67.1.425","article-title":"The ubiquitin system","volume":"67","author":"Hershko","year":"1998","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2026.119005_bib2","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrm1552","article-title":"Proteolysis: from the lysosome to ubiquitin and the proteasome","volume":"6","author":"Ciechanover","year":"2005","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119005_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2026.119005_bib4","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119005_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41580-019-0099-1","article-title":"Breaking the chains: deubiquitylating enzyme specificity begets function","volume":"20","author":"Clague","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119005_bib6","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1097\/GIM.0b013e31815bf97c","article-title":"Genetics of parkinson disease","volume":"9","author":"Pankratz","year":"2007","journal-title":"Genet. Med."},{"key":"10.1016\/j.ejmech.2026.119005_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrc2290","article-title":"FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation","volume":"8","author":"Welcker","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119005_bib8","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/B978-0-12-397863-9.00009-2","article-title":"The ubiquitin-proteasome system and cardiovascular disease","volume":"109","author":"Powell","year":"2012","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.ejmech.2026.119005_bib9","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2026.119005_bib10","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1021\/acs.jmedchem.9b01138","article-title":"Advances in discovering deubiquitinating enzyme (DUB) inhibitors","volume":"63","author":"Schauer","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.119005_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41435-021-00125-9","article-title":"USP15: a review of its implication in immune and inflammatory processes and tumor progression","volume":"22","author":"Georges","year":"2021","journal-title":"Gene Immun."},{"key":"10.1016\/j.ejmech.2026.119005_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.dnarep.2019.02.011","article-title":"Role of deubiquitinases in DNA damage response","volume":"76","author":"Le","year":"2019","journal-title":"DNA Repair"},{"key":"10.1016\/j.ejmech.2026.119005_bib13","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s43018-023-00535-w","article-title":"Loss of the receptors ER, PR and HER2 promotes USP15-dependent stabilization of PARP1 in triple-negative breast cancer","volume":"4","author":"Sun","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.ejmech.2026.119005_bib14","doi-asserted-by":"crossref","first-page":"11093","DOI":"10.1093\/nar\/gkac823","article-title":"USP15 promotes cGAS activation through deubiquitylation and liquid condensation","volume":"50","author":"Shi","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2026.119005_bib15","article-title":"USP15 in cancer and other diseases: from diverse functionsto therapeutic targets","volume":"10","author":"Li","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.ejmech.2026.119005_bib16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13046-024-03152-2","article-title":"The deubiquitinase USP15 drives malignant progression of gastric cancer through glucose metabolism remodeling","volume":"43","author":"Huangfu","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119005_bib17","doi-asserted-by":"crossref","DOI":"10.1177\/1533033820967455","article-title":"Overexpression of ubiquitin-specific Protease 15 (USP15) promotes tumor growth and inhibits apoptosis and correlated with poor disease-free survival in hepatocellular carcinoma","volume":"19","author":"Yao","year":"2020","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.ejmech.2026.119005_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s41419-021-03607-w","article-title":"The deubiquitinating enzyme USP15 stabilizes ERalpha and promotes breast cancer progression","volume":"12","author":"Xia","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2026.119005_bib19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nm.2619","article-title":"USP15 stabilizes TGF-Beta receptor I and promotes oncogenesis through the activation of TGF-Beta signaling in glioblastoma","volume":"18","author":"Eichhorn","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmech.2026.119005_bib20","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.str.2019.01.002","article-title":"Structural and functional characterization of ubiquitin variant inhibitors of USP15","volume":"27","author":"Teyra","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2026.119005_bib21","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/nrd3368","article-title":"Impact of high-throughput screening in biomedical research","volume":"10","author":"Macarron","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2026.119005_bib22","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S1359-6446(01)02140-7","article-title":"Cellular platforms for HTS: three case studies","volume":"7","author":"Johnston","year":"2002","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2026.119005_bib23","doi-asserted-by":"crossref","first-page":"11473","DOI":"10.1073\/pnas.0604348103","article-title":"Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries","volume":"103","author":"Inglese","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.ejmech.2026.119005_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/srep44293","article-title":"Alternative exon skipping biases substrate preference of the deubiquitylase USP15 for mysterin\/RNF213, the moyamoya disease susceptibility factor","volume":"7","author":"Kotani","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2026.119005_bib25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/nrm2731","article-title":"Breaking the chains: structure and function of the deubiquitinases","volume":"10","author":"Komander","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejmech.2026.119005_bib26","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bbamcr.2004.10.003","article-title":"Mechanism and function of deubiquitinating enzymes","volume":"1695","author":"Amerik","year":"2004","journal-title":"Biochim. Biophys. Acta Biochim Biophys Acta"},{"key":"10.1016\/j.ejmech.2026.119005_bib27","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1242\/jcs.090985","article-title":"Cellular functions of the DUBs","volume":"125","author":"Clague","year":"2012","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ejmech.2026.119005_bib28","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/nchembio.2528","article-title":"Discovery and characterization of highly potent and selective allosteric USP7 inhibitors","volume":"14","author":"Gavory","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119005_bib29","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.chembiol.2011.08.018","article-title":"Activity-based chemical proteomics accelerates inhibitor development for deubiquitylating enzymes","volume":"18","author":"Altun","year":"2011","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.119005_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0958-1669(99)00054-3","article-title":"Advances in surface plasmon resonance biosensor analysis","volume":"11","author":"Rich","year":"2000","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ejmech.2026.119005_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132508","article-title":"Fully flexible docking of medium sized ligand libraries with RosettaLigand","volume":"10","author":"DeLuca","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2026.119005_bib32","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/jnci\/51.5.1409","article-title":"A human cell line from a pleural effusion derived from a breast carcinoma","volume":"51","author":"Soule","year":"1973","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejmech.2026.119005_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-61779-465-0_10","article-title":"Rosetta ligand docking with flexible XML protocols","volume":"819","author":"Lemmon","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ejmech.2026.119005_bib34","first-page":"3071","article-title":"MCF-7: the first hormone-responsive breast cancer cell line","volume":"57","author":"Levenson","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2026.119005_bib35","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ccr.2006.10.008","article-title":"A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes","volume":"10","author":"Neve","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2026.119005_bib36","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/BF02616120","article-title":"Long-term human breast carcinoma cell lines of metastatic origin: preliminary characterization","volume":"14","author":"Cailleau","year":"1978","journal-title":"In Vitro"},{"key":"10.1016\/j.ejmech.2026.119005_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10549-009-0460-8","article-title":"Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines","volume":"121","author":"Hollestelle","year":"2010","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ejmech.2026.119005_bib38","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.cell.2004.06.006","article-title":"Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis","volume":"117","author":"Yang","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119005_bib39","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1172\/JCI45014","article-title":"Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies","volume":"121","author":"Lehmann","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejmech.2026.119005_bib40","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.cell.2009.04.037","article-title":"Blinded by the light: the growing complexity of p53","volume":"137","author":"Vousden","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2026.119005_bib41","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature737","article-title":"Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization","volume":"416","author":"Li","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119005_bib42","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nrc2723","article-title":"The first 30 years of p53: growing ever more complex","volume":"9","author":"Levine","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119005_bib43","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrc3711","article-title":"Unravelling mechanisms of p53-mediated tumour suppression","volume":"14","author":"Bieging","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2026.119005_bib44","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1631\/jzus.B1400180","article-title":"USP11 regulates p53 stability by deubiquitinating p53","volume":"15","author":"Ke","year":"2014","journal-title":"J. Zhejiang Univ. - Sci. B"},{"key":"10.1016\/j.ejmech.2026.119005_bib45","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nature03445","article-title":"Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy","volume":"434","author":"Farmer","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.119005_bib46","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic","volume":"355","author":"Lord","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2026.119005_bib47","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1021\/acs.jmedchem.4c02792","article-title":"Discovery and optimization of a series of novel morpholine-containing USP1 inhibitors","volume":"68","author":"Zhang","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004502?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426004502?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T06:18:00Z","timestamp":1783923480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426004502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"alternative-id":["S0223523426004502"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119005","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of a potent and selective small-molecule inhibitor of ubiquitin-specific peptidase 15 (USP15) for the treatment of breast cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.119005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119005"}}